- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01584999
Effects on Septic Patient's Microcirculation of the Transfusion of Different Types of Concentrated RBCs.
May 21, 2012 updated by: Abele Donati, MD, Università Politecnica delle Marche
Effects on the Septic Patient's Microcirculation of the Transfusion of Three Different Types of Concentrated Red Blood Cells.
Aim of the study is to evaluate the effects, on microcirculation of septic patient, of three types of RBCs: 1- fresh standard RBCs (storage <10 days); 2-leukodepleted RBCs and 3-old standard RBCs (storage >15 days) respectively.
Before and 1 hour after the transfusion, microcirculation is evaluated using Sidestream Dark Field Imaging (SDF) and Near InfraRed Spectroscopy (NIRS) with vascular occlusion test.
We also monitor temperature, heart rate, mean blood pressure, hemochrome, blood gases, blood lactates and SOFA score.
Study Overview
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ancona
-
Torrette di Ancona, Ancona, Italy, 60126
- University ICU, AOU Ospedali Riuniti
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with sepsis, severe sepsis or septic shock who, according to clinical evaluation, need a hemotransfusion.
Exclusion Criteria:
- Patients under 18 years of age; Pregnancy; Coagulative disorders; Cardiogenic shock (Met<4;)Acute massive bleeding (>8 U)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Fresh not-leukocyte-reduced RBCs
|
RBCs have been transfused in septic patient admitted in ICU
|
Active Comparator: Fresh RBCs leukocyte-reduced
|
RBCs have been transfused in septic patient admitted in ICU
|
Active Comparator: RBCs with storage longer than 15 days
|
RBCs have been transfused in septic patient admitted in ICU
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Microcirculatory Flow Index (MFI) before and after blood transfusion.
Time Frame: One hour after the end of blood transfusion compared with before blood transfusion
|
Microcirculatory Flow Index detected in vivo by side-dark field imaging at sublingual microcirculation.
It represents the quality of blood flow at microcirculatory level.
This study wants to verify any of the considered different types of blood transfused can improve MFI.
|
One hour after the end of blood transfusion compared with before blood transfusion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Perfused Vessel Density (PVD)
Time Frame: One hour after the end of blood transfusion compared with before blood transfusion
|
Perfused Vessel Density detected in vivo by side-dark field imaging at sublingual microcirculation.
It represents the quantity of well perfused vessels at microcirculatory level.
This study wants to verify any of the considered different types of blood transfused can improve PVD.
|
One hour after the end of blood transfusion compared with before blood transfusion
|
StO2 upslope
Time Frame: One hour after the end of blood transfusion compared with before blood transfusion
|
StO2 upslope is measured with Near InfraRed Spectroscopy at the tenar muscle.
It represents the velocity of the recovery of the tissue oxygen saturation after a short period of ischemia of the hand, the Vascular Occlusion Test.
|
One hour after the end of blood transfusion compared with before blood transfusion
|
Arterial Blood Lactate
Time Frame: One hour after the end of blood transfusion compared with before blood transfusion
|
One hour after the end of blood transfusion compared with before blood transfusion
|
|
Arterial pH
Time Frame: One hour after the end of blood transfusion compared with before blood transfusion
|
One hour after the end of blood transfusion compared with before blood transfusion
|
|
SOFA score
Time Frame: One hour after the end of blood transfusion compared with before blood transfusion
|
One hour after the end of blood transfusion compared with before blood transfusion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Abele Donati, MD, Università Politecnica delle Marche
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Damiani E, Adrario E, Luchetti MM, Scorcella C, Carsetti A, Mininno N, Pierantozzi S, Principi T, Strovegli D, Bencivenga R, Gabrielli A, Romano R, Pelaia P, Ince C, Donati A. Plasma free hemoglobin and microcirculatory response to fresh or old blood transfusions in sepsis. PLoS One. 2015 May 1;10(5):e0122655. doi: 10.1371/journal.pone.0122655. eCollection 2015.
- Donati A, Damiani E, Luchetti M, Domizi R, Scorcella C, Carsetti A, Gabbanelli V, Carletti P, Bencivenga R, Vink H, Adrario E, Piagnerelli M, Gabrielli A, Pelaia P, Ince C. Microcirculatory effects of the transfusion of leukodepleted or non-leukodepleted red blood cells in patients with sepsis: a pilot study. Crit Care. 2014 Feb 17;18(1):R33. doi: 10.1186/cc13730.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2011
Primary Completion (Actual)
February 1, 2012
Study Registration Dates
First Submitted
April 23, 2012
First Submitted That Met QC Criteria
April 23, 2012
First Posted (Estimate)
April 25, 2012
Study Record Updates
Last Update Posted (Estimate)
May 23, 2012
Last Update Submitted That Met QC Criteria
May 21, 2012
Last Verified
May 1, 2012
More Information
Terms related to this study
Other Study ID Numbers
- Prot 210163
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Septic Patients
-
Beni-Suef UniversityCompletedSeptic Patients | Nonseptic PatientsEgypt
-
Meir Medical CenterRecruitingSeptic Patients Admitted to the ICUIsrael
-
Centre Hospitalier Universitaire DijonCompleted
-
University of ZurichCompletedPatients in Septic ShockSwitzerland
-
Assiut UniversityUnknownHaemofiltration | Lung Mechanics | Septic Patients
-
The First Hospital of Jilin UniversityNot yet recruitingPatients With Septic Shock Admitted to the ICU on Invasive Mechanical Ventilation
-
Federal University of São PauloBRICNET - Brazilian Research in Intensive Care NetworkNot yet recruitingSeptic Shock | Critically Ill Patients
-
Ayman Anis MetryCompletedEffect of Hypophosphatemia on Septic PatientsEgypt
-
National Research Center for Hematology, RussiaUnknownSeptic Shock | Nonchemotherapy Drug-induced Neutropenia | Neutropenia After Chemotherapy in Oncohematological Patients | Neutropenia in Patients With Aplastic AnemiaRussian Federation
-
Rennes University HospitalTerminated
Clinical Trials on Blood transfusion
-
Hamad Medical CorporationSidra Medical and Research Center; World Anti-Doping Agency; Anti-Doping Lab... and other collaboratorsUnknownBlood Disease | Blood Transfusion, Autologous | Blood Doping | Blood Transfusion, HomologousQatar
-
Hospital PitangueirasUnknown
-
Emory UniversityWithdrawnHematopoietic and Lymphoid Cell Neoplasm | Leukemia | Anemia | Myelodysplastic Syndrome | Aplastic Anemia | Bone Marrow FailureUnited States
-
Haukeland University HospitalDentsply Sirona Implants and ConsumablesCompleted
-
Mahidol UniversityWolf Schleinzer Stiftung zur Wissenschafts- und Bildungsförderung, GermanyCompletedSurgery | Immune Defect | Incompatible Blood TransfusionThailand
-
Assistance Publique - Hôpitaux de ParisCompletedMyocardial Infarction | Anemia | Blood TransfusionSpain, France
-
Oregon Health and Science UniversityNot yet recruitingTraumatic Brain Injury
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedAcute Myeloid Leukemia | Primary Myelofibrosis | Thrombocytopenia | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Venous Thromboembolism | Myelodysplastic Syndrome | B-Cell Non-Hodgkin Lymphoma | Hematopoietic Cell Transplantation Recipient | Chronic Myelogenous Leukemia, BCR-ABL1 Positive and other conditionsUnited States
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, France; Etablissement... and other collaboratorsRecruitingThe Focus is on the Detection of the Consequences of Autologous Blood Transfusion in Healthy VolunteersFrance
-
Direction Centrale du Service de Santé des ArméesFloralis; TIMC-IMAGRecruitingTrauma | Coagulopathy | Acute HemorrhageFrance